Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;29(13):1606-14.
doi: 10.1002/mds.25784. Epub 2013 Dec 27.

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro

Affiliations

DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro

Kirsten G Coupland et al. Mov Disord. 2014 Nov.

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] Mov Disord. 2016 May;31(5):768. doi: 10.1002/mds.26638. Epub 2016 Mar 31. Mov Disord. 2016. PMID: 27156394 No abstract available.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder for which environmental factors influence disease risk and may act via an epigenetic mechanism. The microtubule-associated protein tau (MAPT) is a susceptibility gene for idiopathic PD. Methylation levels were determined by pyrosequencing of bisulfite-treated DNA in a leukocyte cohort (358 PD patients and 1084 controls) and in two brain cohorts (Brain1, comprising 69 cerebellum controls; and Brain2, comprising 3 brain regions from 28 PD patients and 12 controls). In vitro assays involved the transfection of methylated promoter-luciferase constructs or treatment with an exogenous micronutrient. In normal leukocytes, the MAPT H1/H2 diplotype and sex were predictors of MAPT methylation. Haplotype-specific pyrosequencing confirmed that the H1 haplotype had higher methylation than the H2 haplotype in normal leukocytes and brain tissues. MAPT methylation was negatively associated with MAPT expression in the Brain1 cohort and in transfected cells. Methylation levels differed between three normal brain regions (Brain2 cohort, putamen < cerebellum < anterior cingulate cortex). In PD samples, age at onset was positively associated with MAPT methylation in leukocytes. Moreover, there was hypermethylation in the cerebellum and hypomethylation in the putamen of PD patients compared with controls (Brain2 cohort). Finally, leukocyte methylation status was positively associated with blood vitamin E levels, and the effect was more significant in H2 haplotype carriers; this result was confirmed in cells that were exposed to 100 μM vitamin E. The significant effects of sex, diplotype, and brain region suggest that hypermethylation of the MAPT gene is neuroprotective by reducing MAPT expression. The effect of vitamin E on MAPT represents a possible gene-environment interaction.

Keywords: DNA methylation; Parkinson's disease; microtubule-associated protein tau; vitamin E.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram of the MAPT promoter region and CpG island. (A). Polymorphisms predicted to form CpG dinucleotides corresponding to either the H1 or H2 haplotype The region examined by the pyrosequencing assay (inverted triangle), and the polymorphism used to differentiate between H1 and H2 haplotype are indicated. Effect of MAPT diplotype and gender on MAPT promoter methylation in leukocyte DNA from (B) controls, (C) PD individuals. *** = p < 0.0001.
Figure 2
Figure 2
Haplotype-specific pyrosequencing of MAPT methylation. Methylation levels for the two haplotypes in each sample are indicated as paired data. Tissues examined were leukocyte, cerebellum, anterior cingulate cortex (ACC) and putamen. * = p < 0.05.
Figure 3
Figure 3
Effect of MAPT methylation on gene expression. (A) Scatter plot of MAPT methylation versus MAPT expression levels in cerebellum samples of Brain1 cohort (N = 69). Effect of MAPT methylation on PD. (B) In vitro analysis of relative expression in unmethylated (white) versus methylated (black) luciferase reporter constructs in SK-N-F1 cell. Error bars indicate standard error of the mean from five independent experiments. (C) Scatter plot of methylation versus PD age of onset from Leukocyte cohort (N=358). (D) Analysis of relative MAPT methylation in control (white, N = 12) and PD (black, N = 28) patients in cerebellum (W = 185, p = 0.034), anterior cingulate cortex (W = 210.5, p = 0.151) and putamen (W = 384.5, p = 0.001) from Brain2 cohort. Error bars indicate standard error of the mean. * = p < 0.05, ** = p < 0.001.
Figure 4
Figure 4
Effect of vitamin E on MAPT methylation. A + B) Scatter plots of vitamin E versus MAPT methylation levels in individuals segregated by their diplotype status as H1 (H1/H1 homozygotes) and H2 carriers (H1/H2 heterozygotes and H2/H2 heterozygotes). C) Dose response effect of vitamin E on either the H1 (open bar) or H2 (grey bar) of MAPT in SK-N-F1 cells. Methylation levels of each replicate were normalized against the value observed for the H1 haplotype at 0 mM vitamin E. Error bars indicate standard error of the mean from five independent experiments * = p < 0.05, ** = p < 0.001.

References

    1. Bertram L, Tanzi RE. The genetic epidemidogy of neurodegenerative disease. Journal of Clinical Investigation. 2005;115:1449–1457. - PMC - PubMed
    1. Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurology. 2009;8:1150–1157. - PubMed
    1. Houlden H, Singleton AB. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol. 2012;124:325–338. - PMC - PubMed
    1. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nature Genetics. 2009;41:1308–1312. - PMC - PubMed
    1. Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet. 2010;74:97–109. - PMC - PubMed

Publication types

MeSH terms